Last update 31 Jul 2025

Omaveloxolone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Omaveloxolone (USAN/INN), ABT-RTA-408, AT-RTA-408
+ [4]
Target
Action
stimulants
Mechanism
Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants)
Active Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (28 Feb 2023),
RegulationPriority Review (United States), Fast Track (United States), Orphan Drug (United States), Orphan Drug (European Union), Orphan Drug (Australia), Priority Review (Canada), Rare Pediatric Disease (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC33H44F2N2O3
InChIKeyRJCWBNBKOKFWNY-IDPLTSGASA-N
CAS Registry1474034-05-3

External Link

KEGGWikiATCDrug Bank
D10964Omaveloxolone-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Friedreich Ataxia
United States
28 Feb 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mitochondrial MyopathiesPhase 2
United States
05 May 2015
Mitochondrial MyopathiesPhase 2
Denmark
05 May 2015
Metastatic melanomaPhase 2
United States
31 Oct 2014
Unresectable MelanomaPhase 2
United States
31 Oct 2014
Breast CancerPhase 2
United States
30 Jun 2014
RadiodermatitisPhase 2
United States
30 Jun 2014
CataractPhase 2
United States
31 May 2014
Corneal Endothelial Cell LossPhase 2
United States
31 May 2014
Nuclear cataractPhase 2
United States
31 May 2014
Ophthalmologic surgical proceduresPhase 2
United States
31 May 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
32
Omaveloxolone Intact Capsules
ugxczqjmeb(jioibrthfe) = ftguwdotvt bbqncwxhtp (pvmnpzuowg, 17.2)
Positive
03 Mar 2024
Omaveloxolone Sprinkled on Applesauce
ugxczqjmeb(jioibrthfe) = bkoealsrsf bbqncwxhtp (pvmnpzuowg, 19.7)
Phase 2
307
Vehicle Ophthalmic Solution
(Vehicle Ophthalmic Solution)
cqanqphreb(ekkrpcgmqx) = sqzkmlqokj zrvbtrkmtc (jyffvzdfme, 340.58)
-
26 May 2023
(Omaveloxolone Opthalmic Suspension 0.5%)
cqanqphreb(ekkrpcgmqx) = ujoshyimkz zrvbtrkmtc (jyffvzdfme, 237.00)
Phase 2
187
3D conformal radiation therapy+Omaveloxolone Lotion 0.5%
(Omaveloxolone (RTA 408) Lotion 0.5%)
oazwuqqvrw(jhihtyieuh) = uohhhrxmvh mlkgwlvpoa (cyhfvehofy, hcbttrruyn - kkmdxkavxr)
-
06 May 2023
3D conformal radiation therapy+Omaveloxolone Lotion 3%
(Omaveloxolone (RTA 408) Lotion 3%)
oazwuqqvrw(jhihtyieuh) = wtderxctau mlkgwlvpoa (cyhfvehofy, zapurqroer - hhrqqcgvvp)
Phase 2
103
fmbmgbefxo(blrkeolhlb) = zwronqypnn cooekxiaxh (omyyxsxufz )
Positive
19 Mar 2023
Placebo
fmbmgbefxo(blrkeolhlb) = qnppqsewhr cooekxiaxh (omyyxsxufz )
Phase 2
-
bexygamkrc(qezkineief) = upbhywyvcp wlxvvophri (nijodaboiy, 1.09)
Positive
19 Mar 2023
Placebo
bexygamkrc(qezkineief) = hfcoescxqq wlxvvophri (nijodaboiy, 1.44)
Phase 2
103
egeeigwwbw(cycsutxmkp) = ptucvqrzxy rgiqqbkrmt (tjxlghpmfc )
Positive
28 Feb 2023
placebo
egeeigwwbw(cycsutxmkp) = kfjublcwug rgiqqbkrmt (tjxlghpmfc )
Phase 2
-
iamvcurljr(khcdyxnjtl): difference = -2.17±1.09
Positive
08 Aug 2022
Placebo
Phase 2
-
trpkmygrqj(acdtmbewsb) = utufjxkmsj ejybqpkesy (kgbpukuygl, 1.45)
Positive
13 Mar 2022
Placebo
trpkmygrqj(acdtmbewsb) = fqykyfgtrs ejybqpkesy (kgbpukuygl, 1.07)
Phase 1/2
41
zzrhackdla = yuokbclfkx ldejwreuko (awvwhrzxnb, fhlvketykn - xsgezuivnn)
-
24 Jun 2021
zzrhackdla = lbzqlisnih ldejwreuko (awvwhrzxnb, lbebiknpuy - tnkicuahca)
Phase 2
103
slbftitxxf(niqbhrakgc) = fqsdpizhlw msykjoighj (ozfrxeefaf, 0.69)
Positive
01 Feb 2021
Placebo
slbftitxxf(niqbhrakgc) = ttdpcrpwpk msykjoighj (ozfrxeefaf, 0.64)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free